Gut Liver.
2022 Jul;16(4):493-494. 10.5009/gnl220272.
Role of Tegoprazan in Helicobacter pylori Eradication Therapy
- Affiliations
-
- 1Division of Gastroenterology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
- KMID: 2531228
- DOI: http://doi.org/10.5009/gnl220272
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of Helicobacter pylori: A Real-World Evidence Study
- Approach to Patients after Successful Eradication of Helicobacter pylori
- Comparison of Tegoprazan- and Lansoprazole-Based Fourteen-Day Triple Therapies as First-Line Treatments for Helicobacter pylori Eradication
- Helicobacter pylori Eradication in Patients Undergoing Gastrectomy: Diagnosis and Therapy
- Current Status and Future Perspectives of Tegoprazan-Based Helicobacter pylori Eradication Therapy
